It is also interesting whilst not a material number, they have seen some patients have completely discontinued restart on the treatment. Presumably after the new data has been presented (ie more benefits over time), along with GI management guidelines.
"On restarts, we're beginning to see some patients begin to come back onto therapy, but our focus has been on ensuring a very positive treatment initiation. It's important for those patients that have been on therapy for the long term "
- Forums
- ASX - By Stock
- Ann: Q2 2024 update
It is also interesting whilst not a material number, they have...
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.63 |
Change
-1.080(6.46%) |
Mkt cap ! $1.997B |
Open | High | Low | Value | Volume |
$16.61 | $16.65 | $15.54 | $8.354M | 529.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 830 | $15.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.74 | 1484 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 830 | 15.600 |
1 | 4637 | 15.590 |
1 | 500 | 15.580 |
2 | 1484 | 15.570 |
1 | 1361 | 15.560 |
Price($) | Vol. | No. |
---|---|---|
15.740 | 1484 | 2 |
15.800 | 1000 | 2 |
15.810 | 1789 | 1 |
15.850 | 1789 | 1 |
15.880 | 350 | 1 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |